Decreasing Nightmares in Adults with Narcolepsy

Launched by UNIVERSITY OF UTAH · Apr 22, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to see if a non-medication treatment can help reduce nightmares in adults who have narcolepsy, a sleep disorder that can cause excessive daytime sleepiness and sudden sleep attacks. If you have narcolepsy type 1 or type 2 and experience nightmares at least once a week, you may be eligible to participate. To qualify, you should be at least 18 years old, live in the United States, and be able to communicate in English. It’s important that your sleep and medications have been stable for at least a month before joining the study.

Participants will all receive the same treatment, but it will be given at different times during the study. You'll go through three assessments to help the researchers understand how the treatment affects your nightmares. This trial is not yet recruiting, so if you’re interested, keep an eye out for the opportunity to join! Please note that if you are currently receiving therapy for trauma or sleep issues, or have certain medical conditions, you may not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of narcolepsy type 1 or narcolepsy type 2
• • Nightmare frequency of ≥1 times per week
• • Age 18 or older
• • Able to speak, read, and write in English
• • Live in the United States
• • Sleep and medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study
• Exclusion Criteria:
• • Currently engaged in trauma- or sleep-related psychotherapy
• • Previous behavioral treatment for nightmares
• • Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
• • Untreated moderate-severe sleep apnea